Reuters logo
BRIEF-Sanochemia Pharmazeutika: start of a Phase I trial sponsored by Neurana
September 11, 2017 / 8:06 AM / 8 days ago

BRIEF-Sanochemia Pharmazeutika: start of a Phase I trial sponsored by Neurana

Sept 11 (Reuters) - SANOCHEMIA PHARMAZEUTIKA AG:

* PTA-NEWS: SANOCHEMIA PHARMAZEUTIKA AG: SANOCHEMIA - TOLPERISONE USA: START OF CLINICAL PHASE-I TRIAL

* ‍AIM OF CLINICAL STUDY IS TO CONFIRM NON-SEDATIVE PROPERTIES OF TOLPERISONE​

* SANOCHEMIA‘S PARTNER NEURANA ANTICIPATES HAVING TOPLINE RESULTS FROM STUDY IN LATE Q3 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below